Magnesium-substituted calcium phosphate bone cements containing MgO as a separate phase: synthesis and in vitro behavior

2018 ◽  
Vol 28 (3) ◽  
pp. 329-331 ◽  
Author(s):  
Margarita A. Goldberg ◽  
Valeriy V. Smirnov ◽  
Olga S. Antonova ◽  
Dinara R. Khairutdinova ◽  
Sergey V. Smirnov ◽  
...  
RSC Advances ◽  
2016 ◽  
Vol 6 (1) ◽  
pp. 586-596 ◽  
Author(s):  
Miao Sun ◽  
An Liu ◽  
Chiyuan Ma ◽  
Huifeng Shao ◽  
Menghua Yu ◽  
...  

Herein we systematically investigated the biological performance of a β-dicalcium silicate (β-C2S)-based bone cement in comparison with the clinically used calcium phosphate cement (CPC) and Bio-Oss®.


2012 ◽  
Vol 24 (2) ◽  
pp. 355-364 ◽  
Author(s):  
Shuxin Zhou ◽  
Jingzhi Ma ◽  
Ya Shen ◽  
Markus Haapasalo ◽  
N. Dorin Ruse ◽  
...  

Author(s):  
Denton D. Weiss ◽  
Matthew A. Sachs ◽  
Charles R. Woodard

2015 ◽  
Vol 23 (1) ◽  
pp. 1-14
Author(s):  
Sudirman Sahid ◽  
◽  
Nor Shahida Kader Bashah ◽  
Salina Sabudin ◽  
◽  
...  

1987 ◽  
Vol 52 (9) ◽  
pp. 2317-2325 ◽  
Author(s):  
Jan Hlaváček ◽  
Jan Pospíšek ◽  
Jiřina Slaninová ◽  
Walter Y. Chan ◽  
Victor J. Hruby

[8-Neopentylglycine]oxytocin (II) and [8-cycloleucine]oxytocin (III) were prepared by a combination of solid-phase synthesis and fragment condensation. Both analogues exhibited decreased uterotonic potency in vitro, each being about 15-30% that of oxytocin. Analogue II also displayed similarly decreased uterotonic potency in vivo and galactogogic potency. On the other hand, analogue III exhibited almost the same potency as oxytocin in the uterotonic assay in vivo and in the galactogogic assay.


2006 ◽  
Vol 69 (12) ◽  
pp. 976-982 ◽  
Author(s):  
Nenad Ignjatović ◽  
Petar Ninkov ◽  
Vesna Kojić ◽  
Miloš Bokurov ◽  
Vladimir Srdić ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document